Task: Answer the multiple-choice question.
Question: Which compound exhibits a -30.056% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CC12CCC(=O)N1C(C(=O)N1CCN(S(=O)(=O)c3ccccc3F)CC1)CS2
b.) CC1CC(C)(C)CC(=O)C1C(=O)c1ccccc1
Answer: a. CC12CCC(=O)N1C(C(=O)N1CCN(S(=O)(=O)c3ccccc3F)CC1)CS2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC12CCC(=O)N1C(C(=O)N1CCN(S(=O)(=O)c3ccccc3F)CC1)CS2
CC12CCC(=O)N1C(C(=O)N1CCN(S(=O)(=O)c3ccccc3F)CC1)CS2
3-[4-(2-fluorophenyl)sulfonylpiperazine-1-carbonyl]-7a-methyl-2,3,6,7-tetrahydropyrrolo[2,1-b][1,3]thiazol-5-one